🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine whether epratuzumab provides effe...
Status
Terminated
Location
Weill Medical College of Cornell/ New York Presbyterian Hospital
Start Date
2004-08
Trial ID
NCT00113802
Treatments Being Tested
RATIONALE: Radiolabeled monoclonal antibodies can locate cancer cells and d...
Status
Completed
Location
Garden State Cancer Center
Start Date
1998-04
Trial ID
NCT00004084
Treatments Being Tested
The investigators propose a randomized phase 2 study evaluating 90Y-epratuz...
Status
Withdrawn
Location
CHU de Clermont-Ferrand
Start Date
TBD
Trial ID
NCT02844530
Treatments Being Tested
This study will examine the safety of a new genetically engineered antibody...
Status
Completed
Location
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Start Date
2001-02
Trial ID
NCT00011908
Treatments Being Tested
This will be an open label, multiple center, non-randomized, dose-escalatio...
Status
Completed
Location
Research Unit 463 INSERM
Start Date
2002-08
Trial ID
NCT00421395
Treatments Being Tested
The goal of this study is to evaluate a new approach to immunotherapy in NH...
Status
Withdrawn
Location
Helen F. Graham Cancer Center
Start Date
2010-05
Trial ID
NCT01101581
Treatments Being Tested
Determination of the maximum tolerated dose (MTD) of fractionated RIT with ...
Status
Withdrawn
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT02577094
The purpose of this trial is to determine the safety of a 90Y-radiolabeled,...
Status
Completed
Location
Multiple Locations
Start Date
2000-08
Trial ID
NCT00061425
Treatments Being Tested
This Phase II trial is studying how well giving epratuzumab together with a...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2005-02
Trial ID
NCT00098839
The purpose of this trial is to determine the safety of 90Y-hLL2 at differe...
Status
Terminated
Location
Fox Chase Cancer Center
Start Date
2003-03
Trial ID
NCT00054834
Treatments Being Tested